Overview
Printcare provides specialised printing, packaging and digital media solutions to customers across tea, apparel, FMCG, finance, telecommunications and other industries. Its international footprint includes packaging operations in Kenya and India, while its product range includes cartons, sachets, secure prints and sustainable packaging.
The latest quarter marked a meaningful operational recovery: the group moved back into operating profit even though finance costs and other below-line items still left it with a net loss. That improvement has not yet been reflected in the share price.
Price performance
The share fell 22.2% over three months, compared with a 5.6% decline in the ASPI, and lost 35.0% over one year while the index gained 9.3%. The closing price was LKR 40.00 as at 14 August 2026.
Price performance and operations now disagree: the three-month fall coincided with a 6.8-point rise in operating margin, and there was no company news in the last 30 days to explain the decline. The stock sits at 7.3% of its 52-week range, just 5.0% above its low. Recent 60-day volatility was 42.3%, 7.6% below its own one-year level, while trading volume was 24.1% above its recent 60-day average.
Valuation
Printcare trades at 0.62 times book value, placing it at the 4th percentile of 28 manufacturing peers, among the sector's lowest price-to-book valuations. That discount is consistent with the company's negative profitability, including audited ROE of -10.4% for the year ended March 2025; P/E is not meaningful while earnings remain negative.
The indicated dividend yield is 0.0%. The payout has weakened from LKR 8.0 per share in FY2022 to LKR 5.5 in FY2023 and LKR 2.0 in FY2024, so the low book valuation is not being supported by a strengthening distribution record.
News and sentiment
Direct coverage is thin. The only recent material company disclosures were neutral announcements dated 27 March and 22 April 2026 concerning investment in Printcare Digital (Private) Limited; the 90-day news sentiment window records no positive or negative articles.
No confirmed or announced corporate actions are currently listed, leaving the next meaningful company-specific information point as the upcoming filing.
Financials
Revenue rose sharply year-on-year in the quarter ended June 2026. Gross margin was 16.9%, down from 20.1% a year earlier; operating margin improved to 6.6% from -0.2%; and net margin improved to -0.8% from -11.0%. The gross margin was among the weakest comparable June quarters in the company's history, while operating and net margins were middling against their comparable-basis records.
Operating profit turned positive and the net loss narrowed, but the recovery was not sufficient to overcome finance costs and other below-line items. The audited year to March 2025 remained weak, with revenue declining year-on-year and the group falling into loss. The latest quarter is the most current filing, so these conclusions describe the period ended June 2026 rather than the business after that date.
Risks
The largest risk is balance-sheet pressure. At March 2025, total debt was LKR 8.20 billion and gearing reached 121.3% of owners' equity, while operating profit covered finance costs by only -0.24 times. This leaves limited protection if the operating recovery falters.
Liquidity was better but not comfortable, with a current ratio of 1.34. Annual cash conversion was 1.0 times, so the prior-year operating result was broadly matched by cash generation, but free cash flow was negative. Minority shareholders accounted for 32.7% of annual group profit, meaning group earnings and the earnings attributable to CARE shareholders are not the same pool of money.
Outlook
As at 14 August 2026, the next event is the filing for the quarter ending 30 September 2026. Based on the scheduled window, it is expected between 5 November 2026 and 19 January 2027; that filing will show whether the June operating recovery continued and whether finance costs still absorb most of the operating result.
Easier interest-rate conditions could reduce financing pressure across the manufacturing environment, but the company-specific data cannot establish how quickly that would affect Printcare. Sector-wide export growth supports the demand backdrop, while reported labour shortages remain a constraint for manufacturers. The next filing is therefore more informative than the sparse news flow.